C
CorVel Corporation CRVL
$54.57 $0.611.13% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

CorVel Corporation is a publicly traded provider of technology-enabled healthcare and cost-containment services primarily serving the workers’ compensation, auto, and liability insurance markets. The company operates within the managed care, healthcare administration, and insurance services industries, focusing on improving clinical outcomes while controlling medical costs for employers, insurers, and government entities.

CorVel’s core revenue drivers include medical bill review, preferred provider organization (PPO) network access, case management, utilization review, and integrated claims technology solutions. The company is positioned as a vertically integrated managed care provider, combining proprietary technology platforms with nationwide clinical and provider networks. CorVel was founded in 1987 by Gordon Clemons, initially focusing on cost containment services, and evolved through organic growth and acquisitions into a comprehensive managed care and claims technology provider.

Business Operations

CorVel generates revenue through a portfolio of integrated services delivered under its core business units, including CorVel Enterprise Comp, CorVel PPO, and CorVel Case Management, which collectively support claims management, medical cost control, and patient care coordination. These services are typically sold on a fee-for-service or per-transaction basis to insurance carriers, self-insured employers, and third-party administrators.

Operations are primarily domestic, with services delivered across the United States through a combination of centralized technology platforms and localized clinical resources. CorVel controls proprietary claims management software, analytics tools, and a national provider network. The company operates through wholly owned subsidiaries; however, public disclosures do not indicate material joint ventures. Strategic partnerships primarily involve healthcare providers and ancillary service vendors rather than equity-based alliances.

Strategic Position & Investments

CorVel’s strategic direction emphasizes organic growth through technology enhancement, data analytics, and deeper integration of clinical and claims workflows. The company continues to invest in automation, artificial intelligence–supported bill review, and digital engagement tools designed to improve outcomes and reduce claims duration and severity.

Historically, CorVel has pursued selective acquisitions to expand service capabilities and geographic reach, though it has not engaged in large-scale transformative mergers in recent years. Notable subsidiaries and acquired operations have been integrated into its unified service model rather than operated as standalone brands. The company is actively involved in emerging areas such as predictive analytics and outcome-based care management, though specific financial impacts of these initiatives are not separately disclosed. Data inconclusive based on available public sources regarding material minority investments or venture holdings.

Geographic Footprint

CorVel is headquartered in California, United States, and maintains operational offices and clinical staff across major U.S. regions, including the West Coast, Midwest, South, and Northeast. Its nationwide footprint supports a broad client base with multi-state workers’ compensation and liability exposures.

International operations are limited and not a primary revenue driver. Public disclosures indicate that the vast majority of revenue is generated within the United States, with any international activities being ancillary and not material to consolidated financial results. Data inconclusive based on available public sources regarding the scale of non-U.S. operations.

Leadership & Governance

CorVel maintains a long-tenured leadership team with a governance philosophy centered on disciplined growth, operational efficiency, and long-term shareholder value. The company is founder-influenced, with continuity in executive leadership contributing to strategic consistency over multiple business cycles.

Key executives include:

  • Michael G. CombsPresident and Chief Executive Officer
  • Gordon ClemonsExecutive Chairman and Founder

Public filings indicate a relatively lean executive structure compared to larger diversified peers. Additional senior operational and financial leadership roles are disclosed in SEC filings, though titles and responsibilities may vary over time. Data inconclusive based on available public sources regarding a separately designated Chief Financial Officer role.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $181.98
B
AAPL NASDAQ $250.81
B
MSFT NASDAQ $392.92
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $122.43
B
Top Financial Stocks
See All »
B
B
JPM NYSE $287.97
B
V NYSE $300.35
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $53.70
Top Health Care Stocks
See All »
B
LLY NYSE $913.85
B
JNJ NYSE $237.23
B
AMGN NASDAQ $352.54
Top Real Estate Stocks
See All »
B
PLD NYSE $132.79